European Hematology Association - Above and BEYOND: Luspatercept is Efficacious and Well-Tolerated in Patients with Non-Transfusion-Dependent β-Thalassemia

The results of this study will be presented by Professor Ali Taher in the Presidential Symposium. The results of this study will be presented by ProfessorAli Taherin the Presidential Symposium. Presenter:         ProfessorAli T. Taher Affiliation:        American University of BeirutMedical Center, Beirut, Lebanon  Abstract:            #S101 THE BEYOND STUDY: RESULTS OF A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF LUSPATERCEPT...

The results of this study will be presented by Professor Ali Taher in the Presidential Symposium.

Presenter:          Professor Ali T. Taher

Affiliation:          American University of Beirut Medical Center,  Beirut, Lebanon 

Abstract:              #S101  THE BEYOND STUDY: RESULTS OF A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF LUSPATERCEPT IN ADULT PATIENTS WITH NON-TRANSFUSION DEPENDENT BETA-THALASSEMIA

About the EHA Annual Congress: Every June, EHA organizes its Annual Congress in a major European city. This year, due to the persisting COVID19 pandemic, EHA organizes a virtual Congress for the second time. The Congress is aimed at health professionals working in or interested in the field of hematology.

Website: www.ehaweb.org